| Multiple | Now | Sector median | Where it sits |
|---|---|---|---|
| P/E | −418.0× | −7.3× | |
| Price / Book | 162.3× | 1.0× | |
| Price / Sales | 711.0× | 42.8× | |
| Price / Free cash flow | −445.0× | −10.2× | |
| EV / EBITDA | −295.9× | −20.9× | |
| Earnings yield | −0.2% | −9.7% | |
| Free cash flow yield | −0.2% | −3.9% |
| Company | Price | Change | Mkt cap (USD) | P/E | ROE | 1Y |
|---|---|---|---|---|---|---|
BRNAS:BRVEBraveheart Bio Inc · 🇺🇸 NAS | $19.29 | +3.10% | $1.74B | −25.5× | −78.6% | — |
CTNAS:CTYCITY THERAPEUTICS INC · 🇺🇸 NAS | $21.38 | −4.58% | $1.08B | −19.3× | 69.1% | — |
OBNAS:OBXObsidian Therapeutics Inc · 🇺🇸 NAS | $11.89 | +1.02% | $734.48M | 4.9× | 2,275.2% | — |
ATNAS:ATTOAttovia Therapeutics Inc · 🇺🇸 NAS | $13.89 | +1.17% | $634.1M | −10.3× | −40.4% | — |
BLNAS:BLSMBlossomHill Therapeutics Inc · 🇺🇸 NAS | $14.23 | +2.08% | $452.3M | −7.3× | 46.0% |
VONAS:VOGXVogenx Inc · 🇺🇸 NAS | $15.83 | +8.95% | $235.16M | −149.3× | 157.3% | — |
BSNAS:BSEMBioStem Technologies, Inc. · 🇺🇸 NAS | $1.55 | −25.84% | $27.67M | −5.7× | −16.8% | −56.7% |
CNNAS:CNSYCerenome, Inc. · 🇺🇸 NAS | $1.65 | −2.94% | $12.52M | −0.6× | −560.2% | +150.0% |
EONAS:EOCNEocene Ltd. · 🇺🇸 NAS | $2.81 | −1.41% | $2.93M | −0.3× | −65.3% | +95.2% |
